{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:00Z","timestamp":1787109900456,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":5192,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.anpedi.2012.01.007","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T22:30:31Z","timestamp":1331245831000},"page":"360.e1-360.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recomendaciones de la Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica para el seguimiento del ni\u00f1o expuesto al virus de la inmunodeficiencia humana y a f\u00e1rmacos antirretrovirales durante el embarazo y el periodo neonatal"],"prefix":"10.1016","volume":"76","author":[{"given":"A.","family":"Noguera Julian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"De Jos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2012.01.007_bib0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/QAI.0b013e3182167dec","article-title":"Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006","volume":"57","author":"Whitmore","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0010","unstructured":"Plan Nacional del SIDA. Vigilancia epidemiol\u00f3gica del VIH en Espa\u00f1a. Nuevos diagn\u00f3sticos de VIH en Espa\u00f1a [actualizado 30 Jun 2011]. Disponible en: http:\/\/www.msps.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/vigilancia\/InformeVIHSida_Junio_2011.pdf"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0015","unstructured":"Plan Nacional del SIDA. Recomendaciones de la Secretar\u00eda del Plan Nacional sobre el Sida (SPNS), el Grupo de Estudio de SIDA (GeSida\/SEIMC), la Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO) y la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (AEP) para el seguimiento de la infecci\u00f3n por el VIH con relaci\u00f3n a la reproducci\u00f3n, el embarazo y la prevenci\u00f3n de la transmisi\u00f3n vertical. Junio de 2007, en actualizaci\u00f3n. Disponible en: http:\/\/www.mspsi.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/docs\/Recomendaciones_VIH_embarazoyprevencion_Junio2007.pdf"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0020","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Sep. 14, 2011; p. 1-207. Disponible en: http:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGL.pdf"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0025","unstructured":"World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach \u20132010 version. Disponible en: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599818_eng.pdf"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1468-1293.2008.00619.x","article-title":"British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008","volume":"9","author":"De Ruiter","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0035","unstructured":"Plan Nacional del SIDA. Recomendaciones CEVIHP\/SEIP\/AEP\/SPNS para el seguimiento del paciente pedi\u00e1trico infectado por el virus de la inmunodeficiencia humana (VIH). Junio de 2009. Disponible en: http:\/\/www.mspsi.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/publicaciones\/profSanitarios\/recoSeguimientoPediatricoVIHJunio09.pdf"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1468-1293.2008.00639.x","article-title":"Gestational diabetes mellitus in a cohort of HIV-1 infected women","volume":"9","author":"Gonz\u00e1lez-Tom\u00e9","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0045","first-page":"1","article-title":"Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/INF.0b013e3181e0ce05","article-title":"Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus","volume":"29","author":"Duryea","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1157\/13070179","article-title":"Infecci\u00f3n cong\u00e9nita por citomegalovirus en hijos de madres infectadas por el VIH","volume":"62","author":"Mar\u00edn Gabriel","year":"2005","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0060","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/651232","article-title":"Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy","volume":"201","author":"Patel","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0065","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/00002030-200411190-00019","article-title":"Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe","volume":"18","author":"Thorne","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.anpedi.2008.10.021","article-title":"Malformaciones cong\u00e9nitas en una cohorte de ni\u00f1os no infectados, hijos de madres infectadas por el virus de la inmunodeficiencia humana","volume":"70","author":"Fern\u00e1ndez Ibieta","year":"2009","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0075","unstructured":"Antiretroviral Pregnancy Registry Steering Committee Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2011. Wilmington: Registry Coordinating Center; 2011. Disponible en: www.APRegistry.com"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0080","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1542\/peds.112.5.1196","article-title":"Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics","volume":"112","author":"Read","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0085","unstructured":"Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, et al. Phase III randomized trial of the safety and efficacy of 3 neonatal ARV regimens for prevention of intrapartum HIV-1 transmission: NICHD HPTN 040\/PACTG 1043 [abstract 124 LB]. En: 18th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, EE. UU., 5-8 marzo 2011. Disponible en: www.retroconference.org"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0090","first-page":"655","article-title":"Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1","volume":"101","author":"Mugabo","year":"2011","journal-title":"S Afr Med J"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1695-4033(08)75236-6","article-title":"Anemia y neutropenia en una cohorte de ni\u00f1os no infectados hijos de madres seropositivas para el virus de la inmunodeficiencia humana","volume":"69","author":"Fern\u00e1ndez-Ibieta","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002018-200730030-00004","article-title":"Safety of agents used to prevent mother-to-child transmission of HIV: Is there any cause for concern","volume":"30","author":"Thorne","year":"2007","journal-title":"Drug Safety"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/tropej\/47.4.208","article-title":"Thrombocytopenia as a marker of HIV exposure in the neonate","volume":"47","author":"Roux","year":"2001","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0110","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N Eng J Med"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/507645","article-title":"Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children","volume":"194","author":"Pacheco","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0120","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/08035250510042951","article-title":"Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers","volume":"94","author":"Bunders","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0125","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/00002030-200410210-00005","article-title":"Levels and Pattern of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0130","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0135","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.inf.0000086400.93257.74","article-title":"Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy","volume":"22","author":"Alimenti","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0140","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1542\/peds.2004-0955","article-title":"Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals","volume":"114","author":"Noguera","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/em.20298","article-title":"Plasma and cellular markers of 3\u2019-azido-3\u2019-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs","volume":"48","author":"Meng","year":"2007","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/em.20279","article-title":"Clinical mitochondrial dysfunction in uninfected children born to HIV-infected mothers following perinatal exposure to nucleoside analogues","volume":"48","author":"Benhammou","year":"2007","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0155","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e3280d5a786","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children","volume":"21","author":"Brogly","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2165\/00002018-200730100-00004","article-title":"Mitochondrial disorders among infants exposed to HIV and therapy","volume":"30","author":"Funk","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0165","article-title":"Hyperlactatemia and in utero exposure to antiretrovirals. Is the control group the clue?","author":"Soler-Palac\u00edn","year":"2011","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0170","unstructured":"Noguera-Julian A, Rovira N, Mor\u00e9n C, Garrabou G, Nicol\u00e1s M, Cardellach F, et al. Higher mitochondrial DNA content compensates for lower mitochondrial-encoded complex IV activity in antiretroviral-exposed healthy infants [abstract 116]. En: 18th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, EE. UU., 5-8 marzo 2011. Disponible en: www.retroconference.org"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1542\/peds.2008-3076","article-title":"Evaluation and management of the infant exposed to HIV-1 in the United States","volume":"123","author":"Havens","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.2011.100","article-title":"Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants","volume":"305","author":"Jones","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0185","unstructured":"World Health Organization. Revised BCG vaccination guidelines for infants at risk for HIV infection. Weekly Epidemiol Record. 2007;:193-196. Disponible en: http:\/\/www.who.int\/wer\/2007\/wer8221.pdf."},{"key":"10.1016\/j.anpedi.2012.01.007_bib0190","doi-asserted-by":"crossref","first-page":"44.e1","DOI":"10.1016\/j.anpedi.2011.09.010","article-title":"Vacunaci\u00f3n frente a la gripe estacional en la infancia y la adolescencia, Recomendaciones del CAV-AEP para la campa\u00f1a 2011-2012","volume":"76","author":"Moreno-P\u00e9rez","year":"2012","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.inf.0000207398.10466.0d","article-title":"Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission","volume":"25","author":"Briand","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.anpedi.2009.06.019","article-title":"Exposici\u00f3n a antirretrovirales y crecimiento en una cohorte de ni\u00f1os no infectados, hijos de madre con VIH positivo","volume":"71","author":"Fern\u00e1ndez Ibieta","year":"2009","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0205","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1542\/peds.111.1.e52","article-title":"Height, weight, and growth in children born to mothers with HIV-1 infection in Europe","volume":"111","author":"Newell","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0210","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1542\/peds.2006-0525","article-title":"A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy","volume":"118","author":"Alimenti","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0215","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1542\/peds.2009-1112","article-title":"PACTG 219C Team. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants","volume":"125","author":"Williams","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.qai.0000194735.66322.d9","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts","volume":"41","author":"Brogly","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0225","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e328311d18b","article-title":"Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors","volume":"22","author":"Benhammou","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.anpedi.2012.01.007_bib0230","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/01.aids.0000174454.63250.22","article-title":"Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in children of HIV-1-infected Mathers","volume":"19","author":"Bunders","year":"2005","journal-title":"AIDS"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403312000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403312000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:33:55Z","timestamp":1787106835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403312000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1695403312000252"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2012.01.007","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones de la Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica para el seguimiento del ni\u00f1o expuesto al virus de la inmunodeficiencia humana y a f\u00e1rmacos antirretrovirales durante el embarazo y el periodo neonatal","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2012.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}